PG4KDS: A model for the clinical implementation of pre‐emptive pharmacogenetics
James M. Hoffman(St. Jude Children's Research Hospital), Mary V. Relling(St. Jude Children's Research Hospital), Scott C. Howard(Hospital Sant Joan de Déu Barcelona), Ching‐Hon Pui(St. Jude Children's Research Hospital), Mark R. Wilkinson(St. Jude Children's Research Hospital), Cyrine E. Haidar(St. Jude Children's Research Hospital), William E. Evans(St. Jude Children's Research Hospital), Wenjian Yang(St. Jude Children's Research Hospital), Aditya H. Gaur(St. Jude Children's Research Hospital), Ulrike M. Reiss(St. Jude Children's Research Hospital), Kristine R. Crews(St. Jude Children's Research Hospital), Nancy M. Kornegay(St. Jude Children's Research Hospital), Ulrich Broeckel(Medical College of Wisconsin), Donald K. Baker(St. Jude Children's Research Hospital)
American Journal of Medical Genetics Part C Seminars in Medical Genetics
March 1, 2014
Cited by 277
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Treatment of Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2006|2k
Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling
|Cancer Cell|2002|1.9k
Acute lymphoblastic leukaemia
|The Lancet|2008|1.6k